NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹574 Cr | ₹323 Cr | ₹463 Cr | ₹272 Cr | ₹143 Cr |
What is the latest Operating Profit of NEULAND LABORATORIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹574 Cr |
| Mar2025 | ₹323 Cr |
| Mar2024 | ₹463 Cr |
| Mar2023 | ₹272 Cr |
| Mar2022 | ₹143 Cr |
How is Operating Profit of NEULAND LABORATORIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹574 Cr | 77.72 | |
| Mar2025 | ₹323 Cr | -30.12 | |
| Mar2024 | ₹463 Cr | 70.17 | |
| Mar2023 | ₹272 Cr | 90.61 | |
| Mar2022 | ₹143 Cr | - | |
Compare Operating Profit of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹26,410.8 Cr | -4.6% | 9% | 21.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -4.6% |
9% |
21.5% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses